Your browser doesn't support javascript.
loading
Germline TP53 pathogenic variants and breast cancer: A narrative review.
Blondeaux, Eva; Arecco, Luca; Punie, Kevin; Graffeo, Rossella; Toss, Angela; De Angelis, Carmine; Trevisan, Lucia; Buzzatti, Giulia; Linn, Sabine C; Dubsky, Peter; Cruellas, Mara; Partridge, Ann H; Balmaña, Judith; Paluch-Shimon, Shani; Lambertini, Matteo.
Afiliación
  • Blondeaux E; Clinical Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. Electronic address: evablondeaux@gmail.com.
  • Arecco L; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa, Italy; Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Punie K; Department of General Medical Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
  • Graffeo R; Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.
  • Toss A; Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.
  • De Angelis C; Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy.
  • Trevisan L; Hereditary Cancer Unit, Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Buzzatti G; Hereditary Cancer Unit, Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Linn SC; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Dubsky P; Breast Centre, Hirslanden Klinik St Anna, Luzern, Switzerland.
  • Cruellas M; Department of Medical Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Balmaña J; Department of Medical Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Paluch-Shimon S; Breast Cancer Unit, Sharett Institute of Oncology, Hadassah Medical Center & Faculty of Medicine, Hebrew University, 91120 Jerusalem, Israel.
  • Lambertini M; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa, Italy; Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Cancer Treat Rev ; 114: 102522, 2023 Mar.
Article en En | MEDLINE | ID: mdl-36739824
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias de la Mama / Proteína p53 Supresora de Tumor / Síndrome de Li-Fraumeni Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Límite: Child / Female / Humans Idioma: En Revista: Cancer Treat Rev Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias de la Mama / Proteína p53 Supresora de Tumor / Síndrome de Li-Fraumeni Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Límite: Child / Female / Humans Idioma: En Revista: Cancer Treat Rev Año: 2023 Tipo del documento: Article